AU2024900198A0 - The process of producing exosomes containing mir-299-5p for the treatment of Alzheimer's disease. - Google Patents

The process of producing exosomes containing mir-299-5p for the treatment of Alzheimer's disease.

Info

Publication number
AU2024900198A0
AU2024900198A0 AU2024900198A AU2024900198A AU2024900198A0 AU 2024900198 A0 AU2024900198 A0 AU 2024900198A0 AU 2024900198 A AU2024900198 A AU 2024900198A AU 2024900198 A AU2024900198 A AU 2024900198A AU 2024900198 A0 AU2024900198 A0 AU 2024900198A0
Authority
AU
Australia
Prior art keywords
alzheimer
disease
treatment
exosomes containing
containing mir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024900198A
Inventor
Mahdi Jafarlou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jafarlou, Mahdi DR
Original Assignee
Jafarlou, Mahdi DR
Filing date
Publication date
Application filed by Jafarlou, Mahdi DR filed Critical Jafarlou, Mahdi DR
Publication of AU2024900198A0 publication Critical patent/AU2024900198A0/en
Pending legal-status Critical Current

Links

AU2024900198A 2024-01-29 The process of producing exosomes containing mir-299-5p for the treatment of Alzheimer's disease. Pending AU2024900198A0 (en)

Publications (1)

Publication Number Publication Date
AU2024900198A0 true AU2024900198A0 (en) 2024-02-08

Family

ID=

Similar Documents

Publication Publication Date Title
HUP0100420A2 (en) Novel macrolides and process for preparing them
CA2171882A1 (en) Inhibitors of .beta.-amyloid protein production
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
CA2501799A1 (en) Pyrazole compounds for treatment of neurodegenerative disorders
HUT58334A (en) Process for producing diazines and pharmaceutical compositions containing them as active components
HUT57984A (en) Process for producing pharmaceutical compositions comprising modafinil
TNSN95051A1 (en) PROCESS FOR PRODUCING A PHARMACEUTICAL FORM OF AZITHROMYCIN
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
WO2001060826A3 (en) SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
SG151336A1 (en) 1,3,4-oxadiazol-2-ones as ppar delta
HUT73433A (en) Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders
FI903752A0 (en) FREQUENCY FRAGMENTATION OF 1,2,3,4-TETRAHYDRO-9-ACRIDINAMINDERIVAT.
HK1104280A1 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
WO2003068147A3 (en) Treatments for neurotoxicity in alzheimer’s disease
RS8504A (en) Novel cyclohexil sulphones
AU2024900198A0 (en) The process of producing exosomes containing mir-299-5p for the treatment of Alzheimer's disease.
EP0769957A4 (en) Methods for treating motor deficits
CA2331461A1 (en) Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
AU2024900264A0 (en) Exospmes isolated from Wharton’s jelly have emerged as a novel therapeutic approach for the treatment of Alzheimer's disease.
WO2002076437A3 (en) Methods for treating neurodegenerative diseases including alzheimer's
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
WO2023177376A3 (en) The use of the molecule hydroquinidine in the treatment of brain tumors
MXPA04001951A (en) Coniosulphides and their derivatives, method for their production and use as medicaments.
AU4788696A (en) New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
EP4087654A4 (en) Treatment of alzheimer's disease